Vycor Medical Inc (VYCO) stock
VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.07+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.24MP/E –Yield –
Vycor Medical operating margin
Operating margin is operating income as a percentage of revenue.
Vycor Medical's operating margin for the twelve months ending Jun 30, 2026 was 2.7%. For fiscal 2025 it was 1.8%, against -0.6% the year before. The highest annual figure on record is 2.8% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.8% | +2.4 |
| FY2024 | Dec 31, 2024 | -0.6% | −3.3 |
| FY2023 | Dec 31, 2023 | 2.8% | +27.8 |
| FY2022 | Dec 31, 2022 | -25.1% | +6.2 |
| FY2021 | Dec 31, 2021 | -31.3% | +32.4 |
| FY2020 | Dec 31, 2020 | -63.7% | −20.5 |
| FY2019 | Dec 31, 2019 | -43.2% | +44.1 |
| FY2018 | Dec 31, 2018 | -87.3% | +7.5 |
| FY2017 | Dec 31, 2017 | -94.8% | +14.8 |
| FY2016 | Dec 31, 2016 | -109.5% | +65.3 |
| FY2015 | Dec 31, 2015 | -174.9% | +43.7 |
| FY2014 | Dec 31, 2014 | -218.5% | −9.1 |
| FY2013 | Dec 31, 2013 | -209.4% | +22.4 |
| FY2012 | Dec 31, 2012 | -231.8% | +244.6 |
| FY2011 | Dec 31, 2011 | -476.4% | +135.3 |
| FY2010 | Dec 31, 2010 | -611.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 1.6% | −8.7 |
| Q1 FY2026 | Mar 31, 2026 | 10.0% | +12.9 |
| Q4 FY2025 | Dec 31, 2025 | -8.8% | −13.0 |
| Q3 FY2025 | Sep 30, 2025 | 6.2% | +15.2 |
| Q2 FY2025 | Jun 30, 2025 | 10.3% | +6.3 |
| Q1 FY2025 | Mar 31, 2025 | -2.9% | −0.1 |
| Q4 FY2024 | Dec 31, 2024 | 4.2% | +25.0 |
| Q3 FY2024 | Sep 30, 2024 | -9.0% | −0.7 |
| Q2 FY2024 | Jun 30, 2024 | 4.0% | −16.0 |
| Q1 FY2024 | Mar 31, 2024 | -2.8% | −12.0 |
| Q4 FY2023 | Dec 31, 2023 | -20.8% | +12.8 |
| Q3 FY2023 | Sep 30, 2023 | -8.3% | +20.1 |
| Q2 FY2023 | Jun 30, 2023 | 20.0% | +42.7 |
| Q1 FY2023 | Mar 31, 2023 | 9.2% | +26.1 |
| Q4 FY2022 | Dec 31, 2022 | -33.6% | +26.4 |
| Q3 FY2022 | Sep 30, 2022 | -28.4% | −1.8 |
| Q2 FY2022 | Jun 30, 2022 | -22.7% | −27.5 |
| Q1 FY2022 | Mar 31, 2022 | -16.9% | +53.1 |
| Q4 FY2021 | Dec 31, 2021 | -60.0% | +0.0 |
| Q3 FY2021 | Sep 30, 2021 | -26.6% | +48.2 |
| Q2 FY2021 | Jun 30, 2021 | 4.8% | +86.4 |
| Q1 FY2021 | Mar 31, 2021 | -69.9% | −25.5 |
| Q4 FY2020 | Dec 31, 2020 | -60.0% | −7.0 |
| Q3 FY2020 | Sep 30, 2020 | -74.8% | −23.5 |
| Q2 FY2020 | Jun 30, 2020 | -81.6% | −49.9 |
| Q1 FY2020 | Mar 31, 2020 | -44.4% | +2.0 |
| Q4 FY2019 | Dec 31, 2019 | -53.0% | +56.0 |
| Q3 FY2019 | Sep 30, 2019 | -51.3% | −22.2 |
| Q2 FY2019 | Jun 30, 2019 | -31.7% | +102.8 |
| Q1 FY2019 | Mar 31, 2019 | -46.4% | +50.3 |
| Q4 FY2018 | Dec 31, 2018 | -109.0% | +25.6 |
| Q3 FY2018 | Sep 30, 2018 | -29.1% | +48.9 |
| Q2 FY2018 | Jun 30, 2018 | -134.5% | −19.5 |
| Q1 FY2018 | Mar 31, 2018 | -96.8% | −26.8 |
| Q4 FY2017 | Dec 31, 2017 | -134.7% | +0.6 |
| Q3 FY2017 | Sep 30, 2017 | -78.0% | +18.8 |
| Q2 FY2017 | Jun 30, 2017 | -115.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -70.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -135.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -96.8% | – |
See a number that looks wrong?